Targeting P2RX7: A Promising Approach To Drug Development (G5027)

Target Name: P2RX7

NCBI ID: G5027

P2RX7

Targeting P2RX7: A Promising Approach To Drug Development

The identification and characterization of potential drug targets and biomarkers is a crucial aspect of drug development. One of the most promising avenues for drug research is the use of small molecules, such as proteins, to target various cellular components and pathways. One such protein that Has gained significant attention in recent years is the protein P2RX7, also known as ATP receptor.

P2RX7: Structure and Function

P2RX7 is a protein that plays a critical role in the regulation of cell signaling pathways, particularly in the process of cell signaling by ATP. It is a member of the P2RX family of proteins, which are known to regulate various cellular processes, including cell signaling , DNA replication, and protein synthesis.

The P2RX7 protein is a 12-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is highly conserved, with a calculated pI of 5.5 and a predicted localization in the cytoplasm. P2RX7 has a unique structure that consists of a catalytic domain, a transmembrane region, and an optional cytoplasmic tail.

The catalytic domain of P2RX7 is a characteristic region that is involved in protein-protein interactions and catalytic activity. It contains a catalytic core that is composed of a unique heptadectral arrangement of amino acids that are involved in the formation of a hydrogen bond with other amino acids in the protein. This arrangement is thought to be important for the stability and functional relevance of the catalytic core.

The transmembrane region of P2RX7 is a well-conserved region that is involved in the regulation of protein signaling. It contains a variable region that is involved in the formation of the protein-protein interaction and the regulation of protein stability.

The cytoplasmic tail of P2RX7 is a region that is involved in the regulation of protein stability and localization. It contains a regions that are involved in the interaction with various cellular components, including the endoplasmic reticulum and the cytosol.

P2RX7: Druggability and Therapeutic Potential

The drug targeting of P2RX7 is an attractive prospect due to its unique structure and the involvement of various cellular processes. Several studies have demonstrated the potential of small molecules as drugs that can interact with P2RX7 and modulate its activity.

One of the most promising strategies for drug targeting of P2RX7 is the use of small molecules that can modulate the activity of P2RX7. Several studies have shown that P2RX7 is a potent target for small molecules that can modulate its activity, including inhibitors of the phosphatidylinositol ( PI) signaling pathway.

In addition to small molecules, the use of protein biomarkers can also be a valuable tool for the identification of drug targets. The P2RX7 protein is a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

In conclusion, the protein P2RX7 is a promising drug target due to its unique structure and the involvement of various cellular processes. The use of small molecules and protein biomarkers can help to identify and modulate the activity of P2RX7, leading to new therapeutic opportunities for various diseases. Further research is needed to fully understand the mechanisms of P2RX7 and its potential as a drug target.

Protein Name: Purinergic Receptor P2X 7

Functions: Receptor for ATP that acts as a ligand-gated ion channel. Responsible for ATP-dependent lysis of macrophages through the formation of membrane pores permeable to large molecules. Could function in both fast synaptic transmission and the ATP-mediated lysis of antigen-presenting cells. In the absence of its natural ligand, ATP, functions as a scavenger receptor in the recognition and engulfment of apoptotic cells (PubMed:21821797, PubMed:23303206)

The "P2RX7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about P2RX7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets